| Literature DB >> 15803020 |
Keechilat Pavithran1, Dinesh C Doval.
Abstract
Leukemia as a second malignancy after treatment of thyroid cancer is rare. Most cases reported in the literature have occurred after cumulative doses higher than 800 mCi and it is most commonly acute leukemias. We report a case of chronic myeloid leukemia (CML) occurring in a 40-year-old man 14 years after treatment of papillary thyroid carcinoma. Our patient had the longest interval between the diagnosis of CML and administration of 131I.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15803020 DOI: 10.1097/01.coc.0000143845.79889.33
Source DB: PubMed Journal: Am J Clin Oncol ISSN: 0277-3732 Impact factor: 2.339